Principal Health News
Medical Library
Cool Tools
Fitness & Nutrition
Women's Health
Men's Health
Pregnancy
Children's Health
Alternative Health
Lifestyle & Wellness
Ills & Conditions
Health After 60
Work & Health
Dental Health
Self-Care Centers
Brought to you by CVS Caremark

About This Site

Registration

FAQ

Contact Us

Privacy

Terms of Use

Site Awards





Is Pain Undertreated?

In part two of a four-part series on controlling chronic pain, we examine the reasons why the medical community has often failed to bring relief to suffering patients -- and how that's changing.


By Judith Horstmann and Jennifer Biddle
Consumer Health Interactive

If the World War II generation was more likely to tough out intractable pain, baby boomers who come to doctors for pain relief expect results. In some cases, they may be disappointed. However well-intentioned, the medical community has often failed to bring relief to suffering patients. This discomforting reality can be traced to at least three factors: inadequate training, limited treatment options, and outdated attitudes.

Doctors rarely receive extensive training in treating chronic pain in medical school, and even the general pain information they learned may be outmoded, says Russell Portenoy, chair of the Department of Pain Medicine and Palliative Care at Beth Israel Medical Center in New York City and past president of the American Pain Society. That's beginning to change, as the American Academy of Family Physicians, the American Academy of Pain Management, and other groups offer seminars and special sessions in pain management. (Encouragingly, 72 percent of chronic pain patients in a recent nationwide survey described their doctors as "supportive and friendly," and nearly 60 percent had experienced some relief).

Where drug options are concerned, doctors have long selected from a discouragingly short list. Most research on drugs to relieve pain has focused where aches originate: the skin and other tissues outside the central nervous system, known collectively as the periphery. "Today's most popular remedies -- aspirin and other NSAIDs -- largely work their magic in the periphery," wrote Allan I. Basbaum and David Julius in a 2006 issue of Scientific American. "Stubbing a toe or leaning against a hot stove activates neurons (nerve cells) called nociceptors that respond specificially to hurtful stimuli. When a tissue is injured, a variety of cells in the area pump out chemicals called prostagladins, which act on the pain-sensing branches" of those nerve cells. Aspirin and NSAIDs, the authors explain, cut back on the activity of a family of enzymes that cells use to pump out the prostaglandins that lead to pain.

The problem, Basbaum and Julius point out, is that NSAIDs can keep cells from pumping out prostaglandin in other parts of the body, sometimes leading to side effects such as stomach pain, diarrhea, and ulcers. This can interfere with their long-term use and force doctors to limit their dosages as well. (Also, in many cases, prostaglandins are not the cause of the pain. In those cases, NSAIDs will be ineffective.)

Doctors may prescribe acetaminophen, commonly known as Tylenol, in combination with opioid drugs like hydrocodone (Vicodin) or oxycodone (Percocet). Acetaminophen is effective against many types of pain and is gentler on the stomach than anti-inflammatory drugs. The main concern with acetaminophen is that in large doses the medication may stress or damage the liver.

Clincians may also turn to anesthetics such as lidocaine, which dentists use to numb gums while repairing teeth, to treat pain; a patch that slowly releases lidocaine is now commonly used for pain stemming from nerve damage. Some antidepressants are also prescribed off-label to treat certain kinds of chronic pain, especially pain caused by nerve injury.

But when these drugs fail to relieve pain, physicians often are left with what feels like an unpalatable choice: narcotics.

The opioid controversy

Opiates have fallen in and out of favor since antiquity, and the controversy continues. Morphine (and its younger opioid cousins like methadone and fentanyl) control the more common types of pain very well, but those drugs are still perceived in some quarters as an undesirable option for non-terminal pain, partly due to concerns about addiction and tolerance. Just ask Thomas Greenly. The kind of hesitation his doctors voiced about the wisdom of prescribing opiates was hardly unheard of.

The reasons are deeply ingrained in American culture. Some experts argue that America's often puritanical attitude toward narcotics -- and some states' strict regulations that affect physicians who prescribe pain drugs -- have led to "opiate phobia" in medicine. In a study published in the Journal of Law, Medicine, & Ethics, Washington and Lee University law and health professor Tim S. Jost reported that doctors are likely intimidated by notices from state Medicaid Drug Use Review programs. Screening for drug abuse and fraud, the DUR program sends letters or other notices to doctors who seem to be prescribing large amounts of morphine or opioids. The letters are often routine, and state prosecutors told Jost they are not interested in prosecuting physicians who are legitimately prescribing these drugs for pain. But in at least one case, a Kansas doctor prescribing narcotics for cancer pain was wrongly prosecuted and served time in prison before being exonerated. Physicians become nervous when they receive a DUR inquiry, and it tends to make them cautious about aggressive pain treatment, Jost says.

Even patients afflicted with severe pain often overestimate the danger of opioids and addiction. A "significant number" of chronic pain sufferers surveyed in one 2004 study, for example, were hesitant to take narcotics -- even though nearly half of them reported that their pain was not under control.

Some of the worries are valid. The drugs often have unpleasant side-effects, such as severe constipation, and they can lead to physical dependency. They may also cause cognitive defects in some patients. However, there's little doubt of their therapeutic value. Over the last decade the benefits of treating cancer patients with morphine and opioids have been confirmed by scores of studies, and clinical trials are showing that other chronic pain patients can also benefit. In three trials involving almost 25,000 patients with no history of drug abuse, only seven became addicted. But that message hasn't reached the public yet, says Dr. Portenoy.

Many physicians are missing it as well, says B. Eliot Cole, a neurologist and psychiatrist who is a former president of the American Academy of Pain Management. "I'm constantly meeting doctors who don't understand how to prescribe them -- confused about their potential risks and benefits, the side effects, new forms of delivery," says Dr. Cole. "And that's just a tragedy."

Old attitudes about treating pain are making matters worse. Traditionally, pain medication has been dispensed and used on an as-needed basis, giving many patients the perception that pain drugs are to be used only when discomfort reaches an unbearable level, says Dr. Portenoy. In some cases patients become so afraid they won't be given more pain medication later if they need it that they hoard pain pills and don't take the medication as directed.

The high toll of chronic pain

In other cases patients think pain should be toughed out. "There's a streak of stoicism out there, the idea that pain is redemptive or good for people in some way," says Dr. Portenoy.

And when patients choose or are forced to bear pain, the consequences can be dire. Recent studies paint a disturbing portrait of unmanaged pain. Not only are rates of depression more prevalent, but in perhaps the most chilling statistic, one study found patients with chronic pain committed suicide at two to three times the rate of the general population, while another found that one-third of those said they, like Thomas Greenly, had seriously considered suicide.

Elderly patients may receive especially spotty pain management. A 1998 study that looked at 13,625 cancer patients in nursing homes found that 30 percent reported daily pain. Yet only 26 percent of those were receiving morphine for their pain, while more than a quarter got no analgesics at all -- not even aspirin. The authors noted that pain appears to be underreported and undertreated in the elderly, even though there is no physiologic basis for a reduction in pain as people age.

Unfortunately, conditions have not changed greatly since then. As the National Institutes of Health reported in 2005, "While advances have been made in the management of pain, these advances have not translated into standard-of-care practices in the clinical setting. A significant proportion of patients report that they are not routinely asked about their pain …and at times are not offered any treatment even when they do report problematic symptoms. Undertreatment is related to fears surrounding the use of opioids [which are] often exaggerated or unfounded….Patients continue to suffer from inadequate relief of their pain."

"Screaming on the inside"

Even patients treated with narcotics report inadequate relief. In a 2006 American Pain Foundation survey of adults taking an opioid for chronic pain, more than half felt "little or no control" over their pain. Three-quarters reported feeling depressed, and more than half said their chronic pain had strained their relationship with family and friends. Intractable pain had cost half of them a job, 86 percent reported trouble sleeping at night, and most admitted that pain had undermined their enjoyment of life.

"People don't understand how debilitating it can be to live with chronic pain," says Andrea Cooper in response to the APF survey. Cooper, who says she has suffered from chronic pain for years, adds, "I may look okay on the outside, but I'm screaming on the inside. It prevents me from doing some of the things I love the most."

Of those surveyed, more than three-quarters were looking for new options to treat their pain. Only 14 percent were satisfied with their current medications. Equally disturbing, less than half said they were getting enough information on effective ways to manage their pain.

"Millions are suffering too much for too long and need more aggressive treatment," says Dr. Portenoy.

Michael Potter, MD, stresses that it's only a relatively small handful of pain sufferers who need daily opioids to manage their pain. An associate professor and family physician at UCSF Medical Center with an expertise in pain management, Potter says that while treating the pain itself, doctors and patients should not stop looking for ways to treat the underlying causes or accompanying illnesses, such as depression, that often make it worse. "Opioids should rarely be the first line of treatment, but they shouldn't be forgotten," he says, especially when the pain is moderate to severe.

And when pain lingers, patients can become frustrated, depressed, angry, even hostile about their doctors' inability to offer relief. Not surprisingly, primary care physicians treating these patients discover they themselves are suffering from a similar cycle of negative emotions.

"My heart sinks when I see certain patients in the waiting room again and again," says Andrew Zalski, former director of the Advocate Illinois Masonic Family Practice Center in Chicago. "The chronic pain patient who can't be helped can be your worst nightmare."

Still, attitudes seem to be changing, as physicians and pain specialists increasingly use narcotics and other medications to relieve chronic pain -- even when people's illnesses are not terminal. And new technologies promise to one day interrupt the cascade of signals transmitting pain to the brain and deliver us from pain that now appears unrelenting.

Part III: Promising new approaches to pain treatment

-- Judith Horstmann is a northern California health reporter who has written for many health and medical publications. Jennifer Biddle is a research associate at Consumer Health Interactive. Part of this story was adapted from an article by Horstmann that was published in Hippocrates magazine.



References


Interview with Thomas Greenly.

Interview with Dr. Harvey Rose.

National Foundation for the Treatment of Pain. Board and Staff Members. http://www.paincare.org/about/board/rose.html

US Department of Health and Human Services. An Update of NIH Pain Research and Related Program Initiatives.

American Pain Society. Pain: The Fifth Vital Sign. http://www.ampainsoc.org/advocacy/fifth.htm

American Board of Medical Specialties. Approved ABMS Specialty Boards & Certificate Categories. http://www.abms.org/approved.asp

National Institute of Neurological Disorders and Stroke. NINDS Chronic Pain Information Page. http://www.ninds.nih.gov/disorders/chronic_pain/chronic_pain.htm

National Institute of Neurological Disorders and Stroke. Pain: Hope Through Research. October 2006. http://www.ninds.nih.gov/disorders/chronic_pain/detail_chronic_pain.htm

Interview with Allan Basbaum.

University of California at Los Angeles, Louise M. Darling Biomedical Library. Relief of Pain and Suffering: The Gate Control Model Opens a New Era in Pain Research. http://www.library.ucla.edu/biomed/his/painexhibit/panel6.htm

Melzack R. et al. Pain Mechanisms: A New Theory. Science. 150(699): 971-9. November 19, 1965.

International Association for the Study of Pain. Phantom Limb Pain. June 2000.

Journal of Dental Education. Pain and the neuromatrix in the brain. December 2001. 65(12):1378-82.

University of California at San Francisco. Department of Anatomy. http://anatomy.ucsf.edu/Pages/basbauma.html

Interview with Richard Chapman.

University of Utah, Pain Research Center. Faculty and Staff. http://www.painresearch.utah.edu/facultystaff.htm

-

Basbaum AI et al. Pain Control. Scientific American. Pages 61-67. June 2006.

American Pain Foundation. Report on Congressional Briefing on Pain Held June 13, 2006. http://www.painfoundation.org/page.asp?file=Action/Briefing061306/BriefingReport2006.htm

Stewart WF et al. Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce. Journal of the American Medical Association. Volume 290, Number 18. November 2003.

University of California at San Francisco. Chronic Pain Targets Baby Boomers. May 2006.

American Pain Foundation. Pain Facts: An Overview of American Pain Surveys. March 2005. http://www.painfoundation.org/page.asp?file=Library/PainSurveys.htm

American Family Physician. Chronic Pain Medicines. March 2004. http://www.aafp.org/afp/20040301/1197ph.html

American Family Physician. Managing Chronic Pain in the Primary Care Setting. July 2002. http://www.aafp.org/afp/20020701/editorials.html

Merck Manual. Treatment: Pain. http://www.merck.com/mmhe/sec06/ch078/ch078d.html

American Pain Foundation. Antidepressants for Pain. January 2005. http://www.painfoundation.org/page.asp?file=QandA/Anti-depressants.htm

Public Financing of Pain Management: Leaky Umbrellas and Ragged Safety Nets. Journal of Law, Medicine & Ethics. Volume 26, Number 4. 1998. https://www.aslme.org/aslmesecure/shop/show_product.php?prod_id=516

Washington and Lee University. Faculty. http://law.wlu.edu/faculty/profiledetail.asp?id=24

Cato Institute. Treating Doctors as Drug Dealers: the DEA’s War on Prescription Pain Killers. June 2005. http://www.cato.org/pubs/pas/pa545.pdf

Johns Hopkins Arthritis. Chronic pain, depression and antidepressants: issues and relationships. http://www.hopkins-arthritis.som.jhmi.edu/mngmnt/depression.html

Bernabei R. Management of pain in elderly patients with cancer. Journal of the American Medical Association. 279(23):1877-82. June 1998.

University of California at San Francisco. Comprehensive Cancer Center.

American Pain Foundation. Voices of Chronic Pain Patient Survey. May 2006.

International Communications Research. Patients Expressed Strong Desire for New Options to Help Manage Their Pain. June 2006. http://www.icrsurvey.com/Study.aspx?f=Endo_6_14_06.htm

National Guideline Clearinghouse. Clinical guideline on appropriate use of local anesthesia for pediatric dental patients. October 2006. http://www.guideline.gov/summary/summary.aspx?ss=15&doc_id=7497&nbr=4442



Reviewed by Michael Potter, MD, an attending physician and associate clinical professor at the University of California, San Franicisco, who is board-certified in family practice.


Our reviewers are members of Consumer Health Interactive's medical advisory board.
To learn more about our writers and editors, click here.

First published March 2, 2007
Last updated June 26, 2008
Copyright © 2007 Consumer Health Interactive


  -

Home | Medical Library | Cool Tools | Fitness & Nutrition | Women's Health
Men's Health | Pregnancy | Children's Health | Alternative Health | Lifestyle & Wellness
Ills & Conditions | Health After 60 | Work & Health | Dental Health | Self-Care Centers

About Principal Health News | Editorial Guidelines | Registration | FAQ | Contact Us | Privacy

Copyright© 2002- Principal Financial Services, Inc. Terms of Use.

We subscribe to the HONcode principles of the Health On the Net Foundation URAC Health Web Site Accreditation Seal